Been using this 10mg ed in two split doses for two weeks now as part of 4 week "cycle", was not planning on using any pct but have decided on nolva for four weeks 40/40/20/20 ed post-cycle to combat shutdown after cycle, after recently experiencing ball-shrinkage and more lethargic loads.

YK-11 "IS NOT A SARM" it is a POWERFUL STEROID that just also happens to be a Myostatin INHIBITOR !!! BUT THE BIG MANUFACTURES DO NOT WANT YOU TO KNOW THAT FACT (that it is not s SARM) BECAUSE THEY ARE MAKING TOO MUCH MONEY SELLING IT AS A SAFE & POWERFUL SARM. plse see the web site below which describes in detail YK-11's "chemical composition" and how it became FALSELY mislabeled as a SARM by the man who discovered it!!! according to the author, of the web site below (who is also a well-known pharmacist/ chemist) he claims that this drug is a very powerful STEROID with very STRONG SIDE EFFECTS. & if he is telling us the truth, then...we as buyers must beware!

https://www.quora.com/What-can-you-tell-me-about-YK11

I haven't been able to find any clinical studies or even studies done on lab animals for that matter. The only studies I have seen have been done on muscle cells in petri dish for crying out loud. I sure the hell wouldn't be putting this into my body without seeing more studies done on it. Way to many unknowns to be wasting my money or health on it.

From what I found it is just like LGD4033 but less androgenic, My guess would be this would be better for a woman to take than LGD4033. For the price I think LDG4033 is a much better deal. I think they are both just as suppressive.

YK-11-OA (TLR-1111) Optimized Analogue is a landmark SARM/Myotrophic modulating analogue with Optimized selectivity for potent myotrophic pathways and marginal effects on other parameters usually associated with classical myotrophic/anabolic agents. Of specific importance, oral bioavailability is extremely high and yields a highly potent agent.

Animal Research:

In direct comparison to to LGD-4033 as the reference for assay upon animal models of anabolism and androgenicity, YK-11-OA demonstrated higher efficacy withing anabolic parameters and lesser androgenicity at equivalent dosages.

Anabolic:Androgenic ratio has been determined to be >25, displaying very marginal androgenicity.

Theorized HED estimates for potential clinical trials:

YK-11-OA (TLR-1111) is theorized from extrapolations from the existing animal data to require dosages of 2.0-5.0mg b.i.d. in males and 0.5mg-2mg b.i.d. in females to achieve optimal effects in humans for the noted indications.

I'm interested too. I did see somewhere that it apparently inhibits Myostatin as well which is awesome if it's true. I'm wondering if like Ostarine it's minimally suppressive to he point that you would be able to run it during a PCT plan. I recovered very well from my last cycle and kept almost all my gains and stayed lean thanks to the osta and gw during my pct. one of the top sources here is gonna start carrying it soon at a good price so I'll probably order it and let one of my "natty" friends take it to see how it affects them. Luckily I have no shortage of guinea pigs to research on